An evaluation of the exposure-efficacy relationship for subcutaneous vedolizumab maintenance treatment of Crohn's disease: Pharmacokinetic findings from VISIBLE 2

被引：0
|
作者：
Chen, C. [1 ]
Rosario, M. [4 ]
Polhamus, D. [5 ]
Zhang, W. [2 ]
Kisfalvi, K. [3 ]
Feagan, B. [7 ]
Sandborn, W. [6 ,8 ]
Vermeire, S.
D'Haens, G. [9 ]
机构：
[1] Takeda, Quantitat Clin Pharmacol, Global Clin Sci, Cambridge, MA USA
[2] Takeda, Res & Dev, Stat & Quantitat Sci, Cambridge, MA USA
[3] Takeda, Res & Dev, Global Clin Sci, Cambridge, MA USA
[4] Takeda, Clin Pharmacol, Deerfield, IL USA
[5] Metrum Res Grp, Tariffville, CT USA
[6] Univ Calif San Diego, Div Gastroenterol, San Diego, CA 92103 USA
[7] Western Univ, Robarts Clin Trials, London, ON, Canada
[8] Univ Hosp Leuven, Dept Gastroenterol, Leuven, Belgium
[9] Amsterdam Univ Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
133
引用
收藏
页码：117 / 118
页数：2
相关论文
共 50 条
  • [21] EFFICACY AND SAFETY OF 2 OR 3 VEDOLIZUMAB INTRAVENOUS INFUSIONS AS INDUCTION THERAPY FOR ULCERATIVE COLITIS AND CROHN'S DISEASE: RESULTS FROM VISIBLE 1 AND 2
    Loftus, Edward V.
    Sandborn, William J.
    Wolf, Douglas C.
    Danese, Silvio
    Chen, Jingjing
    Yao, Xiaopan
    Kisfalvi, Krisztina
    Vermeire, Severine
    GASTROENTEROLOGY, 2019, 156 (06) : S1095 - S1095
  • [22] Efficacy and safety of 2 or 3 vedolizumab intravenous infusions as induction therapy for ulcerative colitis and Crohn's disease: results from VISIBLE 1 and 2
    Loftus, E. V., Jr.
    Sandborn, W. J.
    Wolf, D.
    Danese, S.
    Chen, J.
    Yao, X.
    Kisfalvi, K.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S361 - S362
  • [23] Vedolizumab for the Treatment of Fistulizing Crohn's Disease: An Exploratory Analysis of Data From GEMINI 2
    Feagan, Brian G.
    Schwartz, David A.
    Danese, Silvio
    Rubin, David T.
    Abhyankar, Brihad
    Smyth, Michael D.
    Xu, Jing
    Lasch, Karen
    GASTROENTEROLOGY, 2015, 148 (04) : S274 - S274
  • [24] Efficacy and safety of vedolizumab in Crohn's disease in patients from Asian countries in the GEMINI 2 study
    Banerjee, Rupa
    Chuah, Sai Wei
    Hilmi, Ida Normiha
    Wu, Deng-Chyang
    Yang, Suk-Kyun
    Demuth, Dirk
    Lindner, Dirk
    Adsul, Shashi
    INTESTINAL RESEARCH, 2021, 19 (01) : 83 - +
  • [25] Vedolizumab for the Treatment of Fistulising Crohn's Disease: An Exploratory Analysis of Data From GEMINI 2
    Feagan, B.
    Schwartz, D.
    Danese, S.
    Rubin, D. T.
    Abhyankar, B.
    Smyth, M.
    Xu, J.
    Lasch, K.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S333 - S334
  • [26] Efficacy of Vedolizumab With Concomitant Corticosteroid or Immunomodulator Use in Patients With Crohn's Disease From GEMINI 2
    Colombel, Jean-Frederic
    Loftus, Edward V.
    Siegel, Corey A.
    Lewis, James
    Smyth, Michael D.
    Xu, Jing
    Abhyankar, Brihad
    GASTROENTEROLOGY, 2015, 148 (04) : S277 - S277
  • [27] EFFECTS OF SUBCUTANEOUS VEDOLIZUMAB ON HEALTH-RELATED QUALITY OF LIFE AND WORK PRODUCTIVITY IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE PHASE 3 VISIBLE 2 STUDY
    D'Haens, Geert R.
    Sandborn, William J.
    Zhang, Wenwen
    Kisfalvi, Krisztina
    Wang, Song
    Vermeire, Severine
    GASTROENTEROLOGY, 2020, 158 (06) : S437 - S437
  • [28] Efficacy and safety of vedolizumab with advancing age in patients with Crohn's disease: Results from the GEMINI 2 study
    Yajnik, V.
    Khan, N.
    Dubinsky, M.
    Axler, J.
    Green, A.
    Abhyankar, B.
    Lasch, K.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S244 - S245
  • [29] Efficacy and Safety of Vedolizumab With Advancing Age in Patients With Crohn's Disease: Results From the GEMINI 2 Study
    Yajnik, Vijay
    Khan, Nabeel
    Dubinsky, Marla
    Axler, Jeffrey
    Green, Alexandra
    Abhyankar, Brihad
    Lasch, Karen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S790 - S790
  • [30] Vedolizumab Exposure in Pregnancy: Outcomes From Clinical Studies in Ulcerative Colitis and Crohn's Disease
    Mahadevan, Uma
    Dubinsky, Marla
    Vermeire, Severine
    Abhyankar, Brihad
    Lasch, Karen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S771 - S772
12345